EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Multizentrische StudieOpen Access · CC BY 4.0

Innate [18F]Fluorodeoxyglucose PET bone networks of lung cancer patients predict survival

Rucha Ronghe, Teresa Crespo Gonzalez, Catriona Wimberley, Karla Suchacki, Adriana A S Tavares iD

European Journal of Nuclear Medicine and Molecular Imaging · 2025

DOI: 10.1007/s00259-025-07388-8 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2025. Verfasst von Rucha Ronghe und 4 weiteren Autor:innen. Beteiligte Einrichtung: Edinburgh Medical School, University of Edinburgh, 49 Little France Crescent, Edinburgh, EH16 4SB, UK. Hauptthemen laut MEDLINE: Bone and Bones, Carcinoma, Non-Small-Cell Lung, Fluorodeoxyglucose F18, Lung Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chan Zuckerberg Initiative.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Prognostication of lung cancer patients remains challenging clinically. This study aims to address this problem by investigating the utility of bone glucose metabolism networks as a prognostic biomarker of lung cancer patients. The rationale for targeting bone metabolic networks specifically comes from the long-recognised role of bone in innate immunity and the recent appreciation of the key role bones play in regulating whole-body glucose metabolism.

Methods

This study is a retrospective analysis of data from the multi-centre trial ACRIN 6668 on non-small cell lung carcinoma (NSCLC). Conventional [ 18 F]Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) standardised uptake value (SUV) analysis of lung lesions and bones as well as network analysis of bones were carried out in 34 stage IIIB non-operable NSCLC patients before and after chemoradiation.

Results

Conventional lung tumour SUV peak analysis of PET data cannot predict NSCLC patient survival ( p = 0.23–0.35), while network analysis of bone glucose metabolism pre-chemoradiation can significantly predict patient survival ( p = 0.0003) and identify three distinct clusters of survivors (short-term, long-term and mix-term). Chemoradiation treatment results in homogenisation of the innate survivors’ clusters into adapted mix-term clusters and loss of predictive value of bone glucose metabolism networks ( p = 0.77).

Conclusions

Innate pre-treatment skeletal glucose metabolism networks of NSCLC patients can predict patient survival in contrast with adapted post-treatment networks, supporting the role of bones in both innate immunity and regulation of systemic glucose metabolism. Newly proposed network analysis performs better than conventional SUV PET analysis, and should be considered as a prognostication tool in the management of NSCLC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone and BonesCarcinoma, Non-Small-Cell LungFluorodeoxyglucose F18Lung NeoplasmsPositron-Emission TomographyAdultAgedFemaleHumansMaleMiddle AgedPrognosisRadiopharmaceuticalsRetrospective StudiesSurvival Analysis

Stichwörter der Autor:innen

Lung cancerNetwork analysisPET/CTSurvival[18F]FDG

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Edinburgh Medical School, University of Edinburgh, 49 Little France Crescent, Edinburgh, EH16 4SB, UK.
  • Edinburgh Medical School: Biomedical Sciences, University of Edinburgh, Old Medical School (Doorway 3), Teviot Place, Edinburgh, EH8 9AG, UK.
  • British Heart Foundation-University of Edinburgh Centre for Cardiovascular Science, University of Edinburgh, 47 Little France Crescent, Edinburgh, EH16 4TJ, UK.
  • Edinburgh Imaging, University of Edinburgh, Edinburgh, EH16 4TJ, UK.
  • School of Physics and Astronomy, University of Edinburgh, Edinburgh, EH9 3JW, UK.
  • SRUC, The Roslin Institute, Edinburgh, UK.

ORCID-Profile: Adriana A S Tavares

Förderung

  • Chan Zuckerberg Initiative

Zitieren

APA

Ronghe, R., Crespo Gonzalez, T., Wimberley, C., Suchacki, K., & Tavares, A. A. S. (2025). Innate [18F]Fluorodeoxyglucose PET bone networks of lung cancer patients predict survival. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-025-07388-8

Vancouver

Ronghe R, Crespo Gonzalez T, Wimberley C, Suchacki K, Tavares AAS. Innate [18F]Fluorodeoxyglucose PET bone networks of lung cancer patients predict survival. European Journal of Nuclear Medicine and Molecular Imaging. 2025. doi:10.1007/s00259-025-07388-8

BibTeX
@article{Ronghe2025,
  author = {Ronghe, Rucha and Crespo Gonzalez, Teresa and Wimberley, Catriona and Suchacki, Karla and Tavares, Adriana A S},
  title = {Innate [18F]Fluorodeoxyglucose PET bone networks of lung cancer patients predict survival},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2025},
  doi = {10.1007/s00259-025-07388-8}
}
Kostenlos starten →